Deutsche Bank’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,377,964
| Closed | -$32.5M | – | 3697 |
|
|
2023
Q4 | $32.5M | Buy |
1,377,964
+921,858
| +202% | +$16.4M | 0.02% | 644 |
|
|
2023
Q3 | $6.8M | Sell |
456,106
-369,851
| -45% | -$4.9M | ﹤0.01% | 955 |
|
|
2023
Q2 | $9.04M | Buy |
825,957
+430,868
| +109% | +$4.01M | ﹤0.01% | 1016 |
|
|
2023
Q1 | $3.45M | Buy |
395,089
+267,893
| +211% | +$2.14M | ﹤0.01% | 1399 |
|
|
2022
Q4 | $798K | Hold |
127,196
| – | – | ﹤0.01% | 2186 |
|
|
2022
Q3 | $445K | Hold |
127,196
| – | – | ﹤0.01% | 2440 |
|
|
2022
Q2 | $375K | Sell |
127,196
-37,507
| -23% | -$89.6K | ﹤0.01% | 2770 |
|
|
2022
Q1 | $512K | Sell |
164,703
-4,577
| -3% | -$14.4K | ﹤0.01% | 2731 |
|
|
2021
Q4 | $572K | Buy |
169,280
+2,214
| +1% | +$8.4K | ﹤0.01% | 2751 |
|
|
2021
Q3 | $610K | Sell |
167,066
-240,493
| -59% | -$947K | ﹤0.01% | 2899 |
|
|
2021
Q2 | $1.78M | Sell |
407,559
-112,681
| -22% | -$500K | ﹤0.01% | 2344 |
|
|
2021
Q1 | $2.36M | Buy |
520,240
+469,590
| +927% | +$2.53M | ﹤0.01% | 2053 |
|
|
2020
Q4 | $291K | Buy |
50,650
+2,769
| +6% | +$21K | ﹤0.01% | 3243 |
|
|
2020
Q3 | $347K | Sell |
47,881
-331,276
| -87% | -$1.77M | ﹤0.01% | 2868 |
|
|
2020
Q2 | $1.32M | Sell |
379,157
-2,775,270
| -88% | -$8.01M | ﹤0.01% | 2049 |
|
|
2020
Q1 | $4.67M | Buy |
3,154,427
+2,605,008
| +474% | +$4.37M | ﹤0.01% | 1285 |
|
|
2019
Q4 | $1.07M | Buy |
549,419
+267,428
| +95% | +$1M | ﹤0.01% | 2330 |
|
|
2019
Q3 | $1.44M | Buy |
281,991
+179,774
| +176% | +$1.09M | ﹤0.01% | 2102 |
|
|
2019
Q2 | $730K | Sell |
102,217
-109,965
| -52% | -$1.25M | ﹤0.01% | 3039 |
|
|
2019
Q1 | $2.82M | Buy |
212,182
+149,388
| +238% | +$1.59M | ﹤0.01% | 2244 |
|
|
2018
Q4 | $493K | Sell |
62,794
-91,512
| -59% | -$871K | ﹤0.01% | 3339 |
|
|
2018
Q3 | $1.71M | Buy |
154,306
+18,346
| +13% | +$228K | ﹤0.01% | 2960 |
|
|
2018
Q2 | $1.82M | Sell |
135,960
-72,535
| -35% | -$908K | ﹤0.01% | 3018 |
|
|
2018
Q1 | $2.71M | Buy |
208,495
+105,240
| +102% | +$1.31M | ﹤0.01% | 2673 |
|
|
2017
Q4 | $949K | Sell |
103,255
-260,705
| -72% | -$2.23M | ﹤0.01% | 3225 |
|
|
2017
Q3 | $2.93M | Buy |
363,960
+118,419
| +48% | +$801K | ﹤0.01% | 2274 |
|
|
2017
Q2 | $1.41M | Buy |
245,541
+191,122
| +351% | +$814K | ﹤0.01% | 2791 |
|
|
2017
Q1 | $234K | Buy |
+54,419
| New | +$156K | ﹤0.01% | 3511 |
|
|
2016
Q3 | – | Sell |
-68
| Closed | – | – | 5261 |
|
|
2016
Q2 | $0 | Hold |
68
| – | – | ﹤0.01% | 5385 |
|
|
2016
Q1 | $0 | Sell |
68
-1,494
| -96% | -$1.85K | ﹤0.01% | 5382 |
|
|
2015
Q4 | $2K | Buy |
+1,562
| New | +$2.55K | ﹤0.01% | 5155 |
|
|
2015
Q1 | – | Sell |
-300
| Closed | -$2K | – | 6109 |
|
|
2014
Q4 | $2K | Buy |
+300
| New | +$2.41K | ﹤0.01% | 6023 |
|
Other funds holding CBAY
Deutsche Bank's CBAY Position: Q1 2024 in Review
Deutsche Bank sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 1,377,964 shares — an estimated $32.5M sold.
Deutsche Bank first reported a position in CBAY in Q4 2014 and held it in 32 quarters. The position peaked at $32.5M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.
- Deutsche Bank reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
- Deutsche Bank sold 1,377,964 Cymabay Therapeutics shares in Q1 2024, an estimated $32.5M.
- Deutsche Bank first reported a position in Cymabay Therapeutics in Q4 2014 and held it in 32 quarters.
- Deutsche Bank's Cymabay Therapeutics position peaked at $32.5M in Q4 2023.
- 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.
Based on Deutsche Bank's 13F filing for Q1 2024, filed 15 May 2024.